§ Funding Round
Entrada Therapeutics raised $116M Series B venture round, led by Wellington Management.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|---|---|
| Angel | kush parmar | |
| Organization | — | |
| Organization | — | |
Goldman Sachs | — | — |
Greenspring Associates | — | — |
MPM Capital | — | — |
| Organization | — | |
Point72 | — | — |
| Organization | — | |
| Organization | — | |
Roche | — | — |
TCGX | — | — |
| Organization | — | |
| Organization | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$175M
Top Valuation
-
Entrada Therapeutics raised $116M in a Series B round.
The round was announced on 03/31/21.
The round was led by Wellington Management.
